Pemetrexed (Alimta®): A novel multitargeted antifolate agent

Medicine & Life Sciences

• Folic Acid Antagonists 100%
• Pemetrexed 95%
• Cisplatin 28%
• Mesothelioma 24%
• gemcitabine 23%
• Folic Acid 20%
• glycinamide ribonucleotide 19%
• thymidylate synthase-dihydrofolate reductase 17%
• Hydroxymethyl and Formyl Transferases 17%
• pyrimidine 12%
• purine 11%
• Vitamin B 12 11%
• Enzymes 11%
• Head and Neck Neoplasms 10%
• Vitamins 10%
• Urinary Bladder Neoplasms 9%
• Biochemistry 9%
• Breast 7%
• Lung 5%
• Neoplasms 3%